Physician
Himalaya Family Medicine Clinic PLLC
Himalaya Family Medicine Clinic PLLC was paid $2.50M by Medicaid between Jan 2018 and Dec 2024, across 65 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 57% of everything it billed.
33Billing provider infoHIMALAYA FAMILY MEDICINE CLINIC PLLC
AURORA, CO 80012
AURORA, CO 80012
33aNPI1780026914assigned 07/30/2013
33bProvider typeFamily Medicine Physician
28Total paid$2.50M
24GClaims54,148
24DCodes billed65
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Colorado
Rank by total paid#19 of 532
Median peer was paid$35K
This provider vs. median72×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,959 | $281K | |
| 2019 | 6,006 | $265K | |
| 2020 | 6,068 | $286K | |
| 2021 | 7,903 | $358K | |
| 2022 | 10,796 | $452K | |
| 2023 | 11,154 | $503K | |
| 2024incomplete | 7,262 | $358K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 57% | 17,019 | 15,048 | $1.44M |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 6.5% | 1,472 | 1,439 | $162K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.3% | 2,715 | 2,423 | $158K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 4.7% | 1,183 | 1,137 | $116K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.5% | 1,296 | 1,229 | $113K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.4% | 660 | 605 | $84K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3.1% | 4,371 | 4,040 | $79K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.8% | 431 | 412 | $44K |
| 90674 | 1.7% | 1,996 | 1,916 | $43K | |
| 96127 | 1.5% | 2,600 | 2,413 | $37K | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 1.4% | 1,267 | 1,164 | $35K |
| 99406 | <1% | 2,089 | 1,887 | $20K |
53 more codes
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 1,740 | $19K |
| 91322 | <1% | 140 | $14K | |
| 90715 | <1% | 359 | $14K | |
| 0013A | <1% | 265 | $10K | |
| 90837 | Psychotherapy session, about an hour | <1% | 179 | $10K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,150 | $9K |
| 0134A | <1% | 156 | $8K | |
| 90661 | <1% | 305 | $8K | |
| 0011A | <1% | 189 | $7K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 471 | $6K |
| 0012A | <1% | 157 | $6K | |
| 90480 | <1% | 148 | $6K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 287 | $6K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 56 | $5K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 29 | $5K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,728 | $4K |
| 90651 | <1% | 60 | $4K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 76 | $3K |
| 0064A | <1% | 82 | $3K | |
| 99000 | <1% | 2,825 | $3K | |
| 82962 | <1% | 1,043 | $2K | |
| 81002 | <1% | 878 | $2K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 66 | $2K |
| 90677 | <1% | 13 | $2K | |
| 90756 | <1% | 99 | $2K | |
| 85014 | <1% | 741 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 114 | $1K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 69 | $1K |
| 93000 | <1% | 70 | $1K | |
| 81025 | <1% | 146 | $1K | |
| 87430 | <1% | 67 | $969.02 | |
| H0049 | Alcohol and/or drug screening | <1% | 93 | $922.12 |
| 36416 | <1% | 1,648 | $873.78 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 41 | $619.20 |
| 82947 | <1% | 136 | $581.09 | |
| 90653 | <1% | 30 | $333.96 | |
| 69210 | <1% | 15 | $314.44 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 189 | $261.95 |
| 90694 | <1% | 57 | $248.88 | |
| 81003 | <1% | 96 | $239.84 | |
| 85018 | <1% | 75 | $229.65 | |
| 87400 | <1% | 19 | $218.94 | |
| 90658 | <1% | 13 | $152.08 | |
| 90686 | <1% | 97 | $110.52 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 12 | $0.56 |
| 91313 | 0% | 131 | $0.00 | |
| 90734 | 0% | 12 | $0.00 | |
| 91301 | 0% | 422 | $0.00 | |
| 90688 | 0% | 45 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 121 | $0.00 |
| 91307 | 0% | 15 | $0.00 | |
| 3044F | 0% | 62 | $0.00 | |
| 90619 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKUMAR, BIPIN (PRESIDENT)